The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...

The fierce rivalry between Novo Nordisk and Eli Lilly is alive and well, as the two companies are expected to face off with ...

Indiana is joining other states accusing the pharmaceutical giant of inflating drug costs by more than 1,000%.

Indiana Attorney General Todd Rokita has filed lawsuit against one of the state’s most prominent companies, Eli Lilly and Co.

Eli Lilly (LLY) has shown considerable rally potential, with several occurrences of its stock climbing over 30% in less than two months.

In the last part of November 2025, Eli Lilly and Company (NYSE: LLY) shattered a historic ceiling. The Indianapolis-based drugmaker became the first pharmaceutical company to reach a market ...

Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its ...